ArticleInvestigational new drugs2023

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma.

Kenta Yamaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.